My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Immunization to prevent insulin-dependent diabetes mellitus? The economics of genetic screening and vaccination for diabetes.

    England WL, Roberts SD.

    Ann Intern Med. 1981 Mar;94(3):395-400.PMID: 6784628 [PubMed - indexed for MEDLINE]Related articles

    2.

    A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain.

    Asensi F, De Jose M, Lorente M, Moraga F, Ciuryla V, Arikian S, Casciano R, Vento M.

    Value Health. 2004 Jan-Feb;7(1):36-51.PMID: 14720129 [PubMed - indexed for MEDLINE]Related articles

    3.

    A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.

    Bloom BS, Hillman AL, Fendrick AM, Schwartz JS.

    Ann Intern Med. 1993 Feb 15;118(4):298-306.PMID: 8420448 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents.

    Lieu TA, Finkler LJ, Sorel ME, Black SB, Shinefield HR.

    Pediatrics. 1995 May;95(5):632-8.PMID: 7724297 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Cost effectiveness of vaccination against pneumococcal bacteremia in the elderly: the results in Belgium]

    De Graeve D, Verhaegen J, Ament A, Baltussen R.

    Acta Clin Belg. 2000 Sep-Oct;55(5):257-65. Dutch. PMID: 11109640 [PubMed - indexed for MEDLINE]Related articles

    6.

    Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children.

    Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, Miller MA, Shinefield HR.

    JAMA. 2000 Mar 15;283(11):1460-8.PMID: 10732936 [PubMed - indexed for MEDLINE]Related articles

    7.

    Retrospective cost-effectiveness analyses for polio vaccination in the United States.

    Thompson KM, Tebbens RJ.

    Risk Anal. 2006 Dec;26(6):1423-40.PMID: 17184390 [PubMed - indexed for MEDLINE]Related articles

    8.

    Vaccinating first-year college students living in dormitories for Meningococcal disease: an economic analysis.

    Scott RD 2nd, Meltzer MI, Erickson LJ, De Wals P, Rosenstein NE.

    Am J Prev Med. 2002 Aug;23(2):98-105.PMID: 12121797 [PubMed - indexed for MEDLINE]Related articles

    9.

    Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.

    Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.

    Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44.PMID: 16330737 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

    Ryan J, Zoellner Y, Gradl B, Palache B, Medema J.

    Vaccine. 2006 Nov 17;24(47-48):6812-22. Epub 2006 Aug 4.PMID: 17034909 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

    Hutton DW, Tan D, So SK, Brandeau ML.

    Ann Intern Med. 2007 Oct 2;147(7):460-9.PMID: 17909207 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prevention of adenoviral acute respiratory disease in Army recruits: cost-effectiveness of a military vaccination policy.

    Howell MR, Nang RN, Gaydos CA, Gaydos JC.

    Am J Prev Med. 1998 Apr;14(3):168-75.PMID: 9569216 [PubMed - indexed for MEDLINE]Related articles

    13.

    Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

    Kulasingam SL, Myers ER.

    JAMA. 2003 Aug 13;290(6):781-9.PMID: 12915431 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Pertussis in adolescents and adults: should we vaccinate?

    Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.

    Pediatrics. 2005 Jun;115(6):1675-84.PMID: 15930232 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Predicting cost-benefits before programs are started: looking at conjugate vaccine for invasive pneumococcal infections.

    Hueston WJ, Mainous AG 3rd, Brauer N.

    J Community Health. 2000 Feb;25(1):23-33.PMID: 10706207 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cost-effectiveness of a routine varicella vaccination program for US children.

    Lieu TA, Cochi SL, Black SB, Halloran ME, Shinefield HR, Holmes SJ, Wharton M, Washington AE.

    JAMA. 1994 Feb 2;271(5):375-81.PMID: 8283587 [PubMed - indexed for MEDLINE]Related articles

    17.

    Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.

    Zhou F, Bisgard KM, Yusuf HR, Deuson RR, Bath SK, Murphy TV.

    Pediatrics. 2002 Oct;110(4):653-61.PMID: 12359777 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Economic impact of influenza vaccination in preschool children.

    Cohen GM, Nettleman MD.

    Pediatrics. 2000 Nov;106(5):973-6.PMID: 11061762 [PubMed - indexed for MEDLINE]Related articles

    19.

    Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.

    De Wals P, Coudeville L, Trottier P, Chevat C, Erickson LJ, Nguyen VH.

    Vaccine. 2007 Jul 20;25(29):5433-40. Epub 2007 May 15.PMID: 17560695 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.

    Levine OS, Ortiz E, Contreras R, Lagos R, Vial P, Misraji A, Ferreccio C, Espinoza C, Adlerstein L, Herrera P, et al.

    Am J Epidemiol. 1993 Jun 1;137(11):1221-8.PMID: 8322763 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity